 |
BF30062 |
b-D-Glucopyranoside,3-hydroxy-5-[2-(3-hydroxy-4-methoxyphenyl)ethenyl]phenyl,2-(3,4,5-trihydroxybenzoate), (E)- |
94356-24-8 |
C28H28O13 |
572.5141 |
VIEW DETAILS > |
 |
BF29922 |
Urs-12-en-23-oic acid, 3-(acetyloxy)-11-hydroxy-, (3a,4b,11a)- |
146019-25-2 |
C32H50O5 |
514.7364 |
VIEW DETAILS > |
 |
BF34480 |
N-[[3-[5-methyl-4-[4-[[(1-oxopropyl)amino]sulfonyl]phenyl]-3-isoxazolyl]phenyl]sulfonyl]-propanamide |
1708094-99-8 |
C22H23N3O7S2 |
505.5639 |
VIEW DETAILS > |
 |
BF31786 |
Poziotinib hydrochloride |
1429757-68-5 |
C23H22Cl3FN4O3 |
527.8031831999997 |
VIEW DETAILS > |
 |
BF34743 |
3,3'-(Isopropylazanediyl)bis(1-(4-(2-methoxyethyl)phenoxy)propan-2-ol)hydrochloride |
1486464-40-7 |
C27H42ClNO6 |
512.0785 |
VIEW DETAILS > |
 |
BF31641 |
MELK-IN-1 |
2095596-44-2 |
C31H33N5O4 |
539.6248 |
VIEW DETAILS > |
 |
BF33342 |
tert-Butyl 4-((4-((3-chloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidine-1-carboxylate |
612501-81-2 |
C25H28ClFN4O4 |
502.9656 |
VIEW DETAILS > |
 |
BF28694 |
2-Hydroxy Cabozantinib |
1628530-38-0 |
C28H24FN3O6 |
517.5051 |
VIEW DETAILS > |
 |
BF28682 |
Cabozantinib N-oxide |
1621681-63-7 |
C28H24FN3O6 |
517.5051 |
VIEW DETAILS > |
 |
BF28584 |
Nilotinib EP impurity E |
2119583-26-3 |
C27H20F3N7O |
515.4892 |
VIEW DETAILS > |